Atherosclerotic Cardiovascular Disease
Normal blood glucose after gestational diabetes may indicate ASCVD risk
Women who developed first-time gestational diabetes and returned to normal blood glucose levels after pregnancy may experience a twofold increased risk for developing atherosclerotic CVD, according to new data from the CARDIA study.
NLA scientific statement further cements CAC scoring in primary prevention
The first technique for coronary artery calcium scoring was published in 1990. Given the lack of data at the time on CAC and coronary atherosclerosis burden, the algorithm was remarkable yet unactionable.
Evolocumab may reduce likelihood of future revascularization in established ASCVD
Evolocumab, a PCSK9 inhibitor, in addition to statin therapy for stable atherosclerotic CVD may lower risk for future revascularization with PCI or CABG, according to findings published in the Journal of the American College of Cardiology.
Top news in CV health care disparities: COVID-19, participation in trials and more
Healio and Cardiology Today have aggregated a list of the most-read news on racial disparities in CV health and care.
Race alone may not explain ASCVD risk disparities in FH
Race alone may not explain disparities in risk for atherosclerotic CVD among patients with familial hypercholesterolemia, according to data presented at the virtual National Lipid Association Scientific Sessions.
Experts debate CV benefit of type 2 diabetes drugs for adults with type 1
Type 2 diabetes agents with proven cardiovascular benefit may be useful for patients with type 1 diabetes to prevent atherosclerotic CVD, but more robust data are needed for the type 1 population, according to two speakers who debated the issue.
Ticagrelor-aspirin treatment effect in THALES strongest in ipsilateral stenosis
In new data from the THALES trial of patients with prior stroke, the benefit of ticagrelor plus aspirin for secondary stroke prevention was greatest in those with ipsilateral atherosclerotic stenosis.
Statin use may not meaningfully reduce CV events in patients on dialysis
Among patients with established atherosclerotic heart disease on dialysis, the effect of statins on CV events was modest at best, according to a study published in the American Heart Journal.
ASCVD hospitalizations elevated in Black adults with diabetes
A new study highlights a significant cumulative increase in the rate of hospitalizations for atherosclerotic CVD in Black adults with diabetes.
Pooled cohort equations may overestimate ASCVD risk across spectrum of BMI
The pooled cohort equations for atherosclerotic CVD prediction can be used as a risk-estimation tool for adults across BMI categories, but may overestimate ASCVD risk for individuals in overweight and obese categories.